Target intelligence / Profile preview

Globo H glycosphingolipid

Molecular classification: Glycosphingolipid, Globoside, Antigen

Overview

Globo H glycosphingolipid is a hexasaccharide-containing globoside expressed on the surface of various cancer cells, including breast, prostate, and pancreatic cancers, but not on normal tissues. It plays roles in cell adhesion, signal transduction, and tumor progression/metastasis and is a potential target for cancer immunotherapy.

Other names: Globo Hglobohexaosylceramide

Biological functions

Cell adhesionSignal transductionTumor progressionMetastasis

Disease associations

Cancer

Biomarkers

Globo H expression in cancer cells

Beyond the preview

Go deeper on Globo H glycosphingolipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Globo H glycosphingolipid.

Explore the full profile